Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma

被引：0
|
作者：
Tomasova, Kristyna
Seborova, Karolina
Kroupa, Michal
Horak, Josef
Vodickova, Ludmila
Rob, Lukas
Hruda, Martin
Mrhalova, Marcela
Bartakova, Alena
Bouda, Jiri
Fleischer, Thomas
Kristensen, Vessela
Vodicka, Pavel
Vaclavikova, Radka
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB096
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB096
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Telomere length as a predictor of therapy response and survival in patients diagnosed with ovarian carcinoma
    Tomasova, Kristyna
    Seborova, Karolina
    Kroupa, Michal
    Horak, Josef
    Kavec, Miriam
    Vodickova, Ludmila
    Rob, Lukas
    Hruda, Martin
    Mrhalova, Marcela
    Bartakova, Alena
    Bouda, Jiri
    Fleischer, Thomas
    Kristensen, Vessela N.
    Vodicka, Pavel
    Vaclavikova, Radka
    HELIYON, 2024, 10 (13)
  • [2] Expression of ζ T cells prior to interleukin-2 therapy as a predictor of response and survival in patients with ovarian carcinoma
    Kuss, I
    Rabinowich, H
    Gooding, W
    Edwards, R
    Whiteside, TL
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2002, 17 (06) : 631 - 640
  • [3] Telomere Length and Survival of Patients with Hepatocellular Carcinoma in the United States
    Yang, Baiyu
    Shebl, Fatma M.
    Sternberg, Lawrence R.
    Warner, Andrew C.
    Kleiner, David E.
    Edelman, Daniel C.
    Gomez, Allison
    Dagnall, Casey L.
    Hicks, Belynda D.
    Altekruse, Sean F.
    Hernandez, Brenda Y.
    Lynch, Charles F.
    Meltzer, Paul S.
    McGlynn, Katherine A.
    PLOS ONE, 2016, 11 (11):
  • [4] The Telomere Length In Peripheral Lymphocytes Is a Useful Predictor of the Response to Immunosuppressive Therapy In Patients with Acquired Aplastic Anemia
    Takahashi, Yoshiyuki
    Doisaki, Sayoko
    Nishio, Nobuhiro
    Muramatsu, Hideki
    Shimada, Akira
    Hama, Asahito
    Kojima, Seiji
    BLOOD, 2010, 116 (21) : 848 - 849
  • [5] MIB-1: a predictor of survival in patients with ovarian carcinoma
    Geisler, JP
    Geisler, HE
    Wiemann, MC
    Zhou, Z
    Miller, GA
    Crabtree, W
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1998, 8 (05) : 392 - 396
  • [6] Nuclear shape: An independent predictor of survival in patients with ovarian carcinoma
    Geisler, JP
    Geisler, HE
    Wiemann, MC
    Givens, SS
    Zhou, Z
    Miller, GA
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1998, 8 (02) : 164 - 167
  • [7] Telomere Length as a Predictor of Response to Pioglitazone in Patients with Unremitted Depression: A Preliminary Study
    Rasgon, Natalie
    Lin, Katie Watson
    Lin, Jue
    Epel, Elissa
    Jones, Maile
    Roat-Shumway, Siena
    Blackburn, Elizabeth
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S160 - S161
  • [8] Telomere length as a predictor of response to Pioglitazone in patients with unremitted depression: a preliminary study
    N Rasgon
    K W Lin
    J Lin
    E Epel
    E Blackburn
    Translational Psychiatry, 2016, 6 : e709 - e709
  • [9] Telomere length as a predictor of response to Pioglitazone in patients with unremitted depression: a preliminary study
    Rasgon, N.
    Lin, K. W.
    Lin, J.
    Epel, E.
    Blackburn, E.
    TRANSLATIONAL PSYCHIATRY, 2016, 6 : e709 - e709
  • [10] Telomere length and survival in IPF patients
    Satoh, Hiroaki
    RESPIROLOGY, 2016, 21 (01) : 195 - 195
12345